Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
For centuries, nonsteroidal anti-inflammatory drugs (NSAIDs) have been part of our clinical practice. They started out as drugs with anti-inflammatory and analgesic action, and gradually their use has been expanded to new therapeutic targets, some of which are unrelated to their primary mode of action. Today, our armamentarium includes a large range of compounds, attesting to their utility in the treatment of clinical pathologies ranging from pain and inflammation to prevention and treatment of cancer. On the other hand, although NSAIDs share many common properties, their use poses risks, and physicians should be cognizant of their subtle differences and potential complications. In this context, this review article presents insight into NSAIDs’ pathophysiology and mode of action in the clinical setting, their indications, and their potential side effects. Keywords: nonsteroidal anti-inflammatory drugs, prostaglandins, COX
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519 · cited 3×
“67,68 The APPROVe trial showed a 1.9-fold increase in risk of thrombotic events in patients assigned to the rofecoxib group compared with placebo, whereas the APC trial presented a significant increase in the risk of serious CV events, including CV-related death, myocardial infarction, stroke, and…”
InfluentialMeta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure
(2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.5.ioi50013 · Cited by 329 · cited 2×
“64 Among the COX-2 selective NSAIDs, great variability exists with more potent effect obtained by rofecoxib and etoricoxib.”
Pharmacological agents and impairment of fracture healing: What is the evidence?
Pountos, I., Georgouli, T., Blokhuis, T. J., Pape, H. C., & Giannoudis, P. V. (2008) · Injury · doi:10.1016/j.injury.2007.10.035 · Cited by 168
Self-citationTeeling, J. L., Cunningham, C., Newman, T. A., & Perry, V. H. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.11.006 · Cited by 139
Cited by
Kaempferol and inflammation: from chemistry to medicine
Devi, K. P., Malar, D. S., Nabavi, S. F., Sureda, A., Xiao, J., Nabavi, S. M., & Daglia, M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.002 · Cited by 619
BenSaad, L. A., Kim, K. H., Quah, C. C., Kim, W. R., & Shahimi, M. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1555-0 · Cited by 380
Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs
Lucas, G. N. C., Leitão, A. C. C., Alencar, R. L., Xavier, R. M. F., Daher, E. D. F., & Silva Junior, G. B. D. (2019) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2018-0107 · Cited by 307
Do Nonsteroidal Anti-Inflammatory Drugs Affect Bone Healing? A Critical Analysis
Pountos, I., Georgouli, T., Calori, G. M., & Giannoudis, P. V. (2012) · The Scientific World Journal · doi:10.1100/2012/606404 · Cited by 274
Self-citationCannabinoid Delivery Systems for Pain and Inflammation Treatment
Bruni, N., Della Pepa, C., Oliaro-Bosso, S., Pessione, E., Gastaldi, D., & Dosio, F. (2018) · Molecules · doi:10.3390/molecules23102478 · Cited by 272
Metadata
- Authors
- Pountos, I., Georgouli, T., Bird, H., & Giannoudis, P.
- Venue
- International Journal of Interferon, Cytokine and Mediator Research
- Publisher
- Informa UK Limited
- Published
- 2011-01
- Pages
- 19
- ISSN
- 1179-139X (ISSN-L)
- OpenAlex
- W2144681440
- Cited by
- 94
- References
- 4
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects. https://app.cochat.ai/papers/10.2147/ijicmr.s10200
- The paper
- Pountos, I., Georgouli, T., Bird, H., & Giannoudis, P. (2011). Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects. International Journal of Interferon, Cytokine and Mediator Research. https://doi.org/10.2147/ijicmr.s10200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.